LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/SpineCraft Signs Zimmer Spine Deal
Company News

SpineCraft Signs Zimmer Spine Deal

April 29, 2013 1 min read Premium comments

Advertisement

SpineCraft Signs Zimmer Spine Deal
APEX Spine System / Courtesy: SpineCraft, LLC
Secondary

SpineCraft, LLC announced on April 24 that Zimmer Spine will begin distributing, on an exclusive basis, the company’s APEX Spine System in the U.S., Canada, Australia and New Zealand.

The distribution agreement will include the APEX Deformity, Complex Spine, and Degenerative modules.

A statement from SpineCraft noted that it has expanded the APEX system and now offers dedicated Deformity Titanium Rods in multiple diameters, Open Iliac Connectors and additional configurations of the system’s low profile Rod-to-Rod Connectors. The company has also released a number of new instruments, including the latest generation of an advanced Vertebral Column Derotation System.

At the end of 2012, the company completed a move to a new office location in Westmont, Illinois and has been expanding the number of employees at the company. The company is privately held and was founded in 2004 by its CEO, Wagdy Asaad, M.D., and Kamal Ibrahim, M.D.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy